Abstract
The Effect of Rituximab Treatment and Reducing Immunosuppression on the Development of Post-Transplant Lymphoproliferative Disorder in EBV-Positive Patients after Solid Organ Transplantation
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have